|
|
|
|
||
Re: No. of changes made to "Study of Lymphoseek as a Lymphoid Tissue Targeting Agent in Pediatric Patients With Melanoma, Rhabdomyosarcoma, or Other Solid Tumors".Ends 2021, Subjects reduced, VBD now only optional, MD Anderson added.Also, Navidea is no longer sponsoring the trial-- Cardinal Health's trial now
|
return to message board, top of board |